Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Impact of Thoracic Scanographic Characteristics of Hematologic Malignancy Patients with Mediastinal Mass Syndrome Admitted to the Intensive Care Unit

NCT05694806 is registered in ClinicalTrials.gov with University Hospital, Toulouse as lead sponsor.

NCT NCT05694806
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05694806 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Impact of Thoracic Scanographic Characteristics of Hematologic Malignancy Patients with Mediastinal Mass Syndrome Admitted to the Intensive Care Unit
Lead sponsor
University Hospital, Toulouse
Phase
Observational
Overall status
Recruiting
Start date
June 1, 2022
Completion date
December 1, 2024
Enrollment
125 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mediastinal diseases